Title:
APPLICATION OF TETRAHYDROCANNABIVARIN IN PREVENTION AND/OR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Document Type and Number:
WIPO Patent Application WO/2021/135665
Kind Code:
A1
Abstract:
A composition, containing tetrahydrocannabivarin and at least one of other cannabinoid compounds. An application of tetrahydrocannabivarin in preparation of a product for prevention and/or treatment of pulmonary arterial hypertension and complications thereof. Applications of tetrahydrocannabivarin and a combination of the at least one of other cannabinoid compounds in the preparation of the product for prevention and/or treatment of pulmonary arterial hypertension and complications thereof.
Inventors:
TAN XIN (CN)
WANG SHUBIN (CN)
ZHANG KE (CN)
SUN WUXING (CN)
WANG SHUBIN (CN)
ZHANG KE (CN)
SUN WUXING (CN)
Application Number:
PCT/CN2020/128319
Publication Date:
July 08, 2021
Filing Date:
November 12, 2020
Export Citation:
Assignee:
HANYI BIOTECHNOLOGY BEIJING CO LTD (CN)
International Classes:
A61K31/352; A61K31/05; A61K31/353; A61P1/16; A61P9/12
Domestic Patent References:
| WO2017147691A1 | 2017-09-08 | |||
| WO2018075730A1 | 2018-04-26 |
Foreign References:
| CN109200046A | 2019-01-15 | |||
| CN109200046A | 2019-01-15 | |||
| CN110279678A | 2019-09-27 | |||
| CN109260182A | 2019-01-25 | |||
| CN109260182A | 2019-01-25 | |||
| CN108785298A | 2018-11-13 | |||
| US20190134121A1 | 2019-05-09 |
Attorney, Agent or Firm:
BEIJING LINKTEC IP LAW FIRM (SPECIAL GENERAL PARTNERSHIP) (CN)
Download PDF: